Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
Chao Zhang, Jun Zhong, Wei-Xiang Chen, Xu-Yang Zhang, Yu-Hong Li, Teng-Yuan Zhou, Yong-Jie Zou, Chuan Lan, Lan Li, Zhao-Pan Lai, Hua Feng, Rong Hu Department of Neurosurgery and Key Laboratory of Neurotrauma, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing,...
Guardado en:
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/aa665930e0814896a51b177b1d302911 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:aa665930e0814896a51b177b1d302911 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:aa665930e0814896a51b177b1d3029112021-12-02T14:24:09ZUsage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage1178-2021https://doaj.org/article/aa665930e0814896a51b177b1d3029112021-02-01T00:00:00Zhttps://www.dovepress.com/usage-of-angiotensin-converting-enzyme-inhibitor-or-angiotensin-ii-rec-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Chao Zhang, Jun Zhong, Wei-Xiang Chen, Xu-Yang Zhang, Yu-Hong Li, Teng-Yuan Zhou, Yong-Jie Zou, Chuan Lan, Lan Li, Zhao-Pan Lai, Hua Feng, Rong Hu Department of Neurosurgery and Key Laboratory of Neurotrauma, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, People’s Republic of ChinaCorrespondence: Rong Hu; Hua Feng Email huchrong@tmmu.edu.cn; fenghua8888@vip.163.comBackground: Inflammation plays an essential role in secondary brain injury after intracerebral hemorrhage (ICH). Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) have been suggested to suppress neuroinflammation after central nervous system (CNS) damage in animal models. However, the role of ACEIs and ARBs in ICH patients with hypertension remains unresolved in clinic. The aim of the present study is to evaluate the effect of ACEIs/ARBs on ICH patients with hypertension using a retrospective, single-center data analysis.Methods: ICH patients diagnosed by computerized tomographic (CT) at Southwest Hospital, Third Military Medical University were included in the present research from January 2015 to December 2019. According to the medical history for the usage of antihypertensive drugs, patients were assigned into either ACEIs/ARBs group or non-ACEIs/ARBs group. Demographics, clinical baseline, radiological documents and treatments were collected and these data were statistically analyzed between the two groups.Results: A total of 635 ICH patients with hypertension were included and allocated into 2 groups according to the usage of antihypertensive drugs: 281 in the ACEIs/ARBs group and 354 in the non-ACEIs/ARBs group. The results presented that the 3-months mortality and prevalence of ICH-associated pneumonia were lower in ACEIs/ARBs group than that in non-ACEIs/ARBs group (5.0% vs 11.9%, p=0.002; 58.4% vs 66.7%, p=0.031). While, there was no significant difference in favorable outcome (40.2% vs 33.9%, p=0.101) between the two groups. Furthermore, patients in ACEIs/ARBs group exhibited significantly less perihematomal edema volume on days 3 (23.5 ± 14.4 versus 28.7 ± 20.1 mL, p=0.045) and 7 (21.0 ± 13.7 versus 25.7 ± 17.6 mL, p=0.044), compared to that in non- ACEIs/ARBs group.Conclusion: The usage of ACEIs/ARBs helps decrease mortality, perihematomal edema volume, and prevalence of ICH-associated pneumonia in ICH patients with hypertension.Keywords: angiotensin-converting enzyme inhibitor, angiotensin II receptor blocker, inflammation, intracerebral hemorrhage, ICH-associated pneumoniaZhang CZhong JChen WXZhang XYLi YHZhou TYZou YJLan CLi LLai ZPFeng HHu RDove Medical Pressarticleangiotensin-converting enzyme inhibitorangiotensin ii receptor blockerinflammationintracerebral hemorrhageich-associated pneumoniaNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 17, Pp 355-363 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
angiotensin-converting enzyme inhibitor angiotensin ii receptor blocker inflammation intracerebral hemorrhage ich-associated pneumonia Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 |
| spellingShingle |
angiotensin-converting enzyme inhibitor angiotensin ii receptor blocker inflammation intracerebral hemorrhage ich-associated pneumonia Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Zhang C Zhong J Chen WX Zhang XY Li YH Zhou TY Zou YJ Lan C Li L Lai ZP Feng H Hu R Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage |
| description |
Chao Zhang, Jun Zhong, Wei-Xiang Chen, Xu-Yang Zhang, Yu-Hong Li, Teng-Yuan Zhou, Yong-Jie Zou, Chuan Lan, Lan Li, Zhao-Pan Lai, Hua Feng, Rong Hu Department of Neurosurgery and Key Laboratory of Neurotrauma, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, 400038, People’s Republic of ChinaCorrespondence: Rong Hu; Hua Feng Email huchrong@tmmu.edu.cn; fenghua8888@vip.163.comBackground: Inflammation plays an essential role in secondary brain injury after intracerebral hemorrhage (ICH). Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II receptor blockers (ARBs) have been suggested to suppress neuroinflammation after central nervous system (CNS) damage in animal models. However, the role of ACEIs and ARBs in ICH patients with hypertension remains unresolved in clinic. The aim of the present study is to evaluate the effect of ACEIs/ARBs on ICH patients with hypertension using a retrospective, single-center data analysis.Methods: ICH patients diagnosed by computerized tomographic (CT) at Southwest Hospital, Third Military Medical University were included in the present research from January 2015 to December 2019. According to the medical history for the usage of antihypertensive drugs, patients were assigned into either ACEIs/ARBs group or non-ACEIs/ARBs group. Demographics, clinical baseline, radiological documents and treatments were collected and these data were statistically analyzed between the two groups.Results: A total of 635 ICH patients with hypertension were included and allocated into 2 groups according to the usage of antihypertensive drugs: 281 in the ACEIs/ARBs group and 354 in the non-ACEIs/ARBs group. The results presented that the 3-months mortality and prevalence of ICH-associated pneumonia were lower in ACEIs/ARBs group than that in non-ACEIs/ARBs group (5.0% vs 11.9%, p=0.002; 58.4% vs 66.7%, p=0.031). While, there was no significant difference in favorable outcome (40.2% vs 33.9%, p=0.101) between the two groups. Furthermore, patients in ACEIs/ARBs group exhibited significantly less perihematomal edema volume on days 3 (23.5 ± 14.4 versus 28.7 ± 20.1 mL, p=0.045) and 7 (21.0 ± 13.7 versus 25.7 ± 17.6 mL, p=0.044), compared to that in non- ACEIs/ARBs group.Conclusion: The usage of ACEIs/ARBs helps decrease mortality, perihematomal edema volume, and prevalence of ICH-associated pneumonia in ICH patients with hypertension.Keywords: angiotensin-converting enzyme inhibitor, angiotensin II receptor blocker, inflammation, intracerebral hemorrhage, ICH-associated pneumonia |
| format |
article |
| author |
Zhang C Zhong J Chen WX Zhang XY Li YH Zhou TY Zou YJ Lan C Li L Lai ZP Feng H Hu R |
| author_facet |
Zhang C Zhong J Chen WX Zhang XY Li YH Zhou TY Zou YJ Lan C Li L Lai ZP Feng H Hu R |
| author_sort |
Zhang C |
| title |
Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage |
| title_short |
Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage |
| title_full |
Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage |
| title_fullStr |
Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage |
| title_full_unstemmed |
Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage |
| title_sort |
usage of angiotensin-converting enzyme inhibitor or angiotensin ii receptor blocker in hypertension intracerebral hemorrhage |
| publisher |
Dove Medical Press |
| publishDate |
2021 |
| url |
https://doaj.org/article/aa665930e0814896a51b177b1d302911 |
| work_keys_str_mv |
AT zhangc usageofangiotensinconvertingenzymeinhibitororangiotensiniireceptorblockerinhypertensionintracerebralhemorrhage AT zhongj usageofangiotensinconvertingenzymeinhibitororangiotensiniireceptorblockerinhypertensionintracerebralhemorrhage AT chenwx usageofangiotensinconvertingenzymeinhibitororangiotensiniireceptorblockerinhypertensionintracerebralhemorrhage AT zhangxy usageofangiotensinconvertingenzymeinhibitororangiotensiniireceptorblockerinhypertensionintracerebralhemorrhage AT liyh usageofangiotensinconvertingenzymeinhibitororangiotensiniireceptorblockerinhypertensionintracerebralhemorrhage AT zhouty usageofangiotensinconvertingenzymeinhibitororangiotensiniireceptorblockerinhypertensionintracerebralhemorrhage AT zouyj usageofangiotensinconvertingenzymeinhibitororangiotensiniireceptorblockerinhypertensionintracerebralhemorrhage AT lanc usageofangiotensinconvertingenzymeinhibitororangiotensiniireceptorblockerinhypertensionintracerebralhemorrhage AT lil usageofangiotensinconvertingenzymeinhibitororangiotensiniireceptorblockerinhypertensionintracerebralhemorrhage AT laizp usageofangiotensinconvertingenzymeinhibitororangiotensiniireceptorblockerinhypertensionintracerebralhemorrhage AT fengh usageofangiotensinconvertingenzymeinhibitororangiotensiniireceptorblockerinhypertensionintracerebralhemorrhage AT hur usageofangiotensinconvertingenzymeinhibitororangiotensiniireceptorblockerinhypertensionintracerebralhemorrhage |
| _version_ |
1718391444539965440 |